Determination of the magnitude and enantioselectivity of ligand binding to rat and rabbit serum albumins using immobilized-protein high performance liquid chromatography stationary phases.
Rat, rabbit and human serum albumins were immobilized on an HPLC stationary phase, and the resulting phases were tested for their abilities to determine the extent and enantioselectivity of ligand binding to the respective albumins. A series of achiral and chiral compounds were chromatographed on the phases including benzodiazepinones, non-steroidal anti-inflammatory drugs, amino acids, warfarin and leucovorin. The chromatographic retentions of the benzodiazepinones and one series of nonsteroidal anti-inflammatory agents were compared with protein binding data from ultrafiltration studies. The observed correlation factors (r) were consistently 0.999, indicating that the albumin phases can be used to determine the magnitude of binding to the respective proteins. The enantioselectivity was also investigated, and the results indicate that the stationary phases can be used to determine relative enantioselectivities and intraspecies differences in this stereoselectivity. For example, when R- and S-warfarin were studied, R-warfarin was retained to a greater extent than S-warfarin by the rabbit serum albumin-stationary phase, whereas the opposite enantioselectivity was found for the rat and human albumins. Binding interaction studies were also conducted on the rabbit and rat albumin stationary phases by sequentially adding increasing concentrations of octanoic acid to the chromatographic mobile phase. The octanoic acid reduced the retention of a series of non-steroidal anti-inflammatory agents, and the results of the experiments suggest that the interaction takes place at two or more sites on the albumin molecule and by anti-cooperative allosteric interactions and competitive displacement. The results of this study demonstrate that the immobilized serum albumin columns can be used to quantitate and probe ligand binding interactions.
Massolini
G
G
Department of Oncology, McGill University, Montreal, Quebec, Canada.
Aubry
A F
AF
McGann
A
A
Wainer
I W
IW
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000737:chemistry; D001570:Benzodiazepinones / Q000737:chemistry; D001667:Binding, Competitive; D002210:Caprylates / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D006801:Humans; D008024:Ligands; D011485:Protein Binding / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012709:Serum Albumin / Q000737:chemistry*; D013237:Stereoisomerism; D014462:Ultrafiltration; D014859:Warfarin / Q000737:chemistry
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001570:Benzodiazepinones; D002210:Caprylates; D008024:Ligands; D012709:Serum Albumin; D014859:Warfarin; C031492:octanoic acid